BioCentury
ARTICLE | Clinical News

SD Pharma preclinical data

January 2, 2006 8:00 AM UTC

In a mouse model of liver cancer, SDP-014 was equivalent or slightly better than Taxotere docetaxel in reducing tumor burden with no immunogenicity, detectable hemolysis and vein irritation. SDP-014 ...